Randox Life Sciences has developed a range of products including recombinant proteins, polyclonal antibodies and conjugates targeting drugs of abuse, steroids, hormones and biochemical markers.
These specific life-science products are manufactured at the company's ISO 13485-certified manufacturing plant in the UK.
Drug testing can provide a tool for detecting users and monitoring the compliance of subjects in recovery programmes.
For this reason, Randox offers a range of drug-targeted antibodies for research and development applications.
The company's antibodies and conjugates are specific to a range of drugs-of-abuse targets including antidepressants, barbiturates, benzodiazepines, hallucinogens, opiates, sedatives, stimulants and therapeutic drugs.
Randox's drug-targeted antibodies include anti-haloperidol, anti-methicathinone, anti-norfentanyl and therapeutic antibody anti-theophylline and are suitable for use in the development of in-house detection methods such as ELISA.
The antibodies have corresponding HRP conjugates (tracers) available for free for a limited time only with each order.
